{
  "guideline_id": "I.C.2.r",
  "semantic_title": "Coding Guidelines for Malignant Neoplasm Associated with Transplanted Organ",
  "section_path": "Section I > C. Chapter-Specific Coding Guidelines > 2. Chapter 2: Neoplasms > r. Malignant neoplasm associated with transplanted organ",
  "page_number": 38,
  "content": {
    "full_text": "A malignant neoplasm of a transplanted organ should be coded as a transplant complication. Assign first the appropriate code from category T86.-, Complications of transplanted organs and tissue, followed by code C80.2, Malignant neoplasm associated with transplanted organ. Use an additional code for the specific malignancy. (Evidence: pg no: 38, L70-L75)",
    "summary": "Guidelines for coding malignant neoplasms that develop in transplanted organs as transplant complications (Evidence: pg no: 38, L70-L75)",
    "key_concepts": [
      "Malignant neoplasm in transplanted organ is transplant complication (Evidence: pg no: 38, L70-L71)",
      "T86.- code sequenced first (Evidence: pg no: 38, L71-L72)",
      "C80.2 code follows T86.- code (Evidence: pg no: 38, L74-L75)",
      "Additional code for specific malignancy (Evidence: pg no: 38, L75)"
    ],
    "detailed_rules": [
      {
        "rule_id": "transplant_complication_classification",
        "rule_text": "A malignant neoplasm of a transplanted organ should be coded as a transplant complication (Evidence: pg no: 38, L70-L71)",
        "explanation": "When malignancy develops in a transplanted organ, it is classified as a complication of the transplant rather than just a primary malignancy (Evidence: pg no: 38, L70-L71)",
        "importance": "critical",
        "applies_to": "malignancies in transplanted organs",
        "common_applications": [
          "Skin cancer in transplant recipients",
          "Lymphoma in transplanted organs"
        ]
      },
      {
        "rule_id": "t86_sequencing_priority",
        "rule_text": "Assign first the appropriate code from category T86.- (Evidence: pg no: 38, L71-L72)",
        "explanation": "The transplant complication code takes sequencing priority over other codes in this scenario (Evidence: pg no: 38, L71-L72)",
        "importance": "critical",
        "applies_to": "all transplant-associated malignancies",
        "common_applications": [
          "T86.10 for unspecified kidney transplant complication",
          "T86.40 for unspecified liver transplant complication"
        ]
      },
      {
        "rule_id": "c80_2_requirement",
        "rule_text": "Follow T86.- code with C80.2, Malignant neoplasm associated with transplanted organ (Evidence: pg no: 38, L74-L75)",
        "explanation": "C80.2 is specifically required to identify the malignancy as transplant-associated (Evidence: pg no: 38, L74-L75)",
        "importance": "critical",
        "applies_to": "all transplant-associated malignancies",
        "common_applications": [
          "All cases of malignancy in transplanted organs"
        ]
      },
      {
        "rule_id": "specific_malignancy_additional",
        "rule_text": "Use an additional code for the specific malignancy (Evidence: pg no: 38, L75)",
        "explanation": "The specific type of malignancy must also be coded to provide complete clinical picture (Evidence: pg no: 38, L75)",
        "importance": "high",
        "applies_to": "all transplant-associated malignancies",
        "common_applications": [
          "Specific lymphoma codes",
          "Specific carcinoma codes"
        ]
      }
    ],
    "workflow_steps": [
      "Step 1: Identify malignant neoplasm in transplanted organ",
      "Step 2: Assign appropriate T86.- code as principal diagnosis",
      "Step 3: Add C80.2 as secondary diagnosis",
      "Step 4: Add specific malignancy code as additional diagnosis"
    ],
    "related_terminology": [
      "Transplanted organ",
      "Transplant complication",
      "Malignant neoplasm",
      "Post-transplant malignancy",
      "Immunosuppression-related cancer"
    ]
  },
  "code_references": {
    "code_ranges": [
      {
        "range": "T86.-",
        "description": "Complications of transplanted organs and tissue (Evidence: pg no: 38, L71-L72)",
        "requirement": "Sequenced first for transplant-associated malignancies",
        "usage_rules": [
          "Always sequenced first (Evidence: pg no: 38, L71-L72)",
          "Followed by C80.2 (Evidence: pg no: 38, L74-L75)"
        ]
      }
    ],
    "specific_codes": [
      {
        "code": "C80.2",
        "description": "Malignant neoplasm associated with transplanted organ (Evidence: pg no: 38, L74-L75)",
        "context": "Required for all malignancies in transplanted organs",
        "requires_additional_codes": true,
        "breakdown": {
          "C80": "Malignant neoplasm without specification of site",
          "2": "Associated with transplanted organ"
        }
      }
    ],
    "code_patterns": [
      {
        "pattern": "T86.- + C80.2 + Specific malignancy code",
        "description": "Standard pattern for transplant-associated malignancies (Evidence: pg no: 38, L70-L75)",
        "example": "T86.10 + C80.2 + C83.30",
        "explanation": "Transplant complication, then transplant-associated malignancy, then specific malignancy"
      }
    ],
    "code_categories_mentioned": [
      "Transplant complication codes",
      "Transplant-associated malignancy codes",
      "Specific malignancy codes"
    ]
  },
  "cross_references": {
    "references_to": [],
    "referenced_by": []
  },
  "coding_scenarios": [
    {
      "scenario_id": "kidney_transplant_lymphoma",
      "scenario": "Patient with kidney transplant develops post-transplant lymphoproliferative disorder",
      "documentation_example": "Post-transplant lymphoproliferative disorder in kidney transplant recipient, diffuse large B-cell lymphoma",
      "step_by_step": [
        "Step 1: Identify malignancy (lymphoma) in transplanted organ context",
        "Step 2: Assign T86.10 (unspecified kidney transplant complication) as principal",
        "Step 3: Add C80.2 (malignant neoplasm associated with transplanted organ)",
        "Step 4: Add C83.30 (diffuse large B-cell lymphoma, unspecified site)"
      ],
      "correct_coding": {
        "primary_code": "T86.10 (Unspecified complication of kidney transplant)",
        "secondary_codes": [
          "C80.2 (Malignant neoplasm associated with transplanted organ)",
          "C83.30 (Diffuse large B-cell lymphoma, unspecified site)"
        ],
        "sequencing": "Transplant complication first, then C80.2, then specific malignancy",
        "rationale": "Malignancy in transplanted organ is coded as transplant complication (Evidence: pg no: 38, L70-L75)"
      },
      "incorrect_coding": {
        "code": "C83.30",
        "codes": [
          "C83.30 as principal diagnosis"
        ],
        "rationale": "Should not sequence specific malignancy first in transplant context",
        "common_mistake": "Coding as primary malignancy instead of transplant complication"
      }
    }
  ],
  "procedure_links": [],
  "examples": [],
  "special_notes": {
    "warnings": [
      "Always code malignancy in transplanted organ as transplant complication (Evidence: pg no: 38, L70-L71)"
    ],
    "best_practices": [
      "Use all three code types: T86.-, C80.2, and specific malignancy (Evidence: pg no: 38, L71-L75)",
      "Sequence T86.- code first (Evidence: pg no: 38, L71-L72)"
    ],
    "common_mistakes": [
      "Coding as primary malignancy instead of transplant complication (Evidence: pg no: 38, L70-L71)",
      "Omitting C80.2 code (Evidence: pg no: 38, L74-L75)"
    ],
    "tips": [
      "C80.2 is always required for transplant-associated malignancies (Evidence: pg no: 38, L74-L75)",
      "Three-code pattern is standard for these cases (Evidence: pg no: 38, L71-L75)"
    ],
    "implementation_notes": [],
    "clinical_context": [
      "Applies to post-transplant malignancies related to immunosuppression"
    ]
  },
  "search_keywords": [
    "transplant",
    "malignant neoplasm",
    "transplanted organ",
    "T86",
    "C80.2",
    "transplant complication",
    "post-transplant malignancy"
  ],
  "metadata": {
    "category": "chapter_specific",
    "subcategory": "transplant_complications",
    "complexity_level": "advanced",
    "applies_to_settings": [
      "inpatient",
      "outpatient"
    ],
    "last_updated": "FY 2026",
    "tags": [
      "transplant",
      "malignancy",
      "complications",
      "immunosuppression"
    ]
  },
  "page_range_processed": "pages_36_to_39"
}